{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:28Z","timestamp":1786984348705,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.annemergmed.2022.11.003","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T10:11:51Z","timestamp":1674123111000},"page":"429-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7013-5432","authenticated-orcid":false,"given":"Michael S.","family":"Toce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth A.","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel D.","family":"Hudgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hadland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Monuteaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence T.","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2022.11.003_bib1","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamapediatrics.2021.1832","article-title":"Temporal trends in opioid prescribing practices in children, adolescents, and younger adults in the US from 2006 to 2018","volume":"175","author":"Renny","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-051539","article-title":"Opioid prescribing to US children and young adults in 2019","volume":"148","author":"Chua","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib3","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1542\/peds.2015-1364","article-title":"Prescription opioids in adolescence and future opioid misuse","volume":"136","author":"Miech","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib4","doi-asserted-by":"crossref","first-page":"e191750","DOI":"10.1001\/jamapediatrics.2019.1750","article-title":"Association of nonmedical prescription opioid use with subsequent heroin use initiation in adolescents","volume":"173","author":"Kelley-Quon","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib5","doi-asserted-by":"crossref","first-page":"e1002922","DOI":"10.1371\/journal.pmed.1002922","article-title":"Prescription opioid use and misuse among adolescents and young adults in the United States: A national survey study","volume":"16","author":"Hudgins","year":"2019","journal-title":"PLOS Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jama.2014.18514","article-title":"Mandatory use of prescription drug monitoring programs","volume":"313","author":"Haffajee","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib7","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1377\/hlthaff.2017.1321","article-title":"Four states with robust prescription drug monitoring programs reduced opioid dosages","volume":"37","author":"Haffajee","year":"2018","journal-title":"Health Aff"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1377\/hlthaff.2015.1673","article-title":"Prescription drug monitoring programs are associated with sustained reductions in opioid prescribing by physicians","volume":"35","author":"Bao","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib9","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jamainternmed.2015.3931","article-title":"Effect of Florida\u2019s prescription drug monitoring program and pill mill laws on opioid prescribing and use","volume":"175","author":"Rutkow","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib10","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1377\/hlthaff.2015.1496","article-title":"Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates","volume":"35","author":"Patrick","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib11","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/EDE.0000000000001123","article-title":"Measuring relationships between proactive reporting state-level prescription drug monitoring programs and county-level fatal prescription opioid overdoses","volume":"31","author":"Cerd\u00e1","year":"2020","journal-title":"Epidemiology"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.7326\/M17-3074","article-title":"Association between prescription drug monitoring programs and nonfatal and fatal drug overdoses: a Systematic Review","volume":"168","author":"Fink","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12913-017-2354-5","article-title":"Evaluating the impact of prescription drug monitoring program implementation: a scoping review","volume":"17","author":"Finley","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib15","first-page":"1","article-title":"Association of state-level opioid-reduction policies with pediatric opioid poisoning","volume":"02115","author":"Toce","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jpeds.2015.04.071","article-title":"Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: A national study","volume":"167","author":"Cerd\u00e1","year":"2015","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib18","doi-asserted-by":"crossref","first-page":"e186558","DOI":"10.1001\/jamanetworkopen.2018.6558","article-title":"US national trends in pediatric deaths from prescription and illicit opioids, 1999-2016","volume":"1","author":"Gaither","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1001\/jamapediatrics.2019.4878","article-title":"Association of opioid prescribing patterns with prescription opioid overdose in adolescents and young adults","volume":"174","author":"Chua","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.drugalcdep.2017.05.023","article-title":"Impact of New York prescription drug monitoring program, I-STOP, on statewide overdose morbidity","volume":"178","author":"Brown","year":"2017","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pam.22098","article-title":"Mandatory access prescription drug monitoring programs and prescription drug abuse","volume":"38","author":"Grecu","year":"2019","journal-title":"J\u00a0Policy Anal Manage"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib24","doi-asserted-by":"crossref","first-page":"e2036687","DOI":"10.1001\/jamanetworkopen.2020.36687","article-title":"Systematic evaluation of state policy interventions targeting the US opioid epidemic, 2007-2018","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib25","doi-asserted-by":"crossref","first-page":"e1003272","DOI":"10.1371\/journal.pmed.1003272","article-title":"State-level prescription drug monitoring program mandates and adolescent injection drug use in the United States, 1995-2017: A difference-in-differences analysis","volume":"17","author":"Earlywine","year":"2020","journal-title":"PLOS Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1257\/pol.20160094","article-title":"The effect of prescription drug monitoring programs on opioid utilization in medicare","volume":"10","author":"Buchmueller","year":"2018","journal-title":"Am Econ J Econ Policy"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 opioid guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.annemergmed.2017.03.057","article-title":"The effect of opioid prescribing guidelines on prescriptions by emergency physicians in Ohio","volume":"70","author":"Weiner","year":"2017","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib30","doi-asserted-by":"crossref","first-page":"107754","DOI":"10.1016\/j.drugalcdep.2019.107754","article-title":"The association between pain clinic laws and prescription opioid exposures: new evidence from multi-state comparisons","volume":"206","author":"Liang","year":"2020","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib31","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1111\/add.15359","article-title":"Laws limiting prescribing and dispensing of opioids in the United States, 1989-2019","volume":"116","author":"Davis","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/acem.13121","article-title":"Performance measures of diagnostic codes for detecting opioid overdose in the emergency department","volume":"24","author":"Rowe","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jamainternmed.2018.5419","article-title":"Association of opioid prescriptions from dental clinicians for US adolescents and young adults with subsequent opioid use and abuse","volume":"179","author":"Schroeder","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1377\/hlthaff.2020.01762","article-title":"Adverse events and emergency department opioid prescriptions in adolescents","volume":"40","author":"Worsham","year":"2021","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib35","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamapediatrics.2020.2539","article-title":"Association of opioid prescription initiation during adolescence and young adulthood with subsequent substance-related morbidity","volume":"174","author":"Quinn","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.04.033","article-title":"Impact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: A comparative interrupted time series analysis","volume":"165","author":"Chang","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib37","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/add.13741","article-title":"Do more robust prescription drug monitoring programs reduce prescription opioid overdose?","volume":"112","author":"Pardo","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drugalcdep.2017.12.002","article-title":"Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings","volume":"184","author":"Pauly","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.drugalcdep.2015.09.024","article-title":"Prescription monitoring programs and emergency department visits involving opioids, 2004-2011","volume":"156","author":"Maughan","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib40","first-page":"297","article-title":"State prescription drug monitoring programs and fatal drug overdoses","volume":"23","author":"Nam","year":"2017","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib41","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/add.14440","article-title":"A\u00a0typology of prescription drug monitoring programs: a latent transition analysis of the evolution of programs from 1999 to 2016","volume":"114","author":"Smith","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1204141","article-title":"Effect of abuse-deterrent formulation of OxyContin","volume":"367","author":"Cicero","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib44","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital Signs: Changes in opioid prescribing in the United States, 2006-2015","volume":"66","author":"Guy","year":"2017","journal-title":"Vital Signs. MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib46","first-page":"662","article-title":"Trends in abuse of OxyContin\u00ae and other opioid analgesics in the United States: 2002-2004","volume":"6","author":"Cicero","year":"2005","journal-title":"J\u00a0Pain"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: A rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib49","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/add.15375","article-title":"Commentary on Hill et\u00a0al.: breaking down barriers\u2014increasing access to lifesaving opioid use disorder medications to save lives","volume":"116","author":"Toce","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.drugpo.2019.10.001","article-title":"Prescription drug monitoring programs operational characteristics and fatal heroin poisoning","volume":"74","author":"Martins","year":"2019","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.annemergmed.2022.11.003_bib51","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.2105\/AJPH.2016.303104","article-title":"Prescription and illicit opioid deaths and the Prescription Drug Monitoring Program in Florida","volume":"106","author":"Delcher","year":"2016","journal-title":"Am J Public Health"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064422012549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064422012549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T04:48:17Z","timestamp":1759294097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064422012549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0196064422012549"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2022.11.003","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Prescription Drug Monitoring Programs With Opioid Prescribing and Overdose in Adolescents and Young Adults","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American College of Emergency Physicians.","name":"copyright","label":"Copyright"}]}}